Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$116 Mln
P/E Ratio
--
P/B Ratio
11.09
Industry P/E
24.53
Debt to Equity
1.48
ROE
-3.3 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-0.47
CFO
$-99.75 Mln
EBITDA
$-84.01 Mln
Net Profit
$-99.96 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Augmedix Inc (AUGX)
| -59.83 | 1.29 | 152.69 | -54.37 | -26.83 | -- | -- |
|
BSE Sensex*
| 1.48 | 4.01 | 3.03 | 8.65 | 11.66 | 20.20 | 11.03 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
|
|---|---|---|
|
Augmedix Inc (AUGX)
| 275.00 | -50.48 |
|
S&P Small-Cap 600
| 13.89 | -17.42 |
|
BSE Sensex
| 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go... Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California. Read more
President, CEO, Secretary & Director
Mr. Emmanuel Krakaris
President, CEO, Secretary & Director
Mr. Emmanuel Krakaris
Headquarters
San Francisco, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Augmedix Inc (AUGX) stood at $ 78 Mln as on 30-Jun-24
The share price of Augmedix Inc (AUGX) is $2.35 (NASDAQ) as of 02-Oct-2024 09:30 EDT. Augmedix Inc (AUGX) has given a return of -26.83% in the last 3 years.
Augmedix Inc (AUGX) has a market capitalisation of $ 116 Mln as on 02-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Augmedix Inc (AUGX) is 11.09 times as on 02-Oct-2024, a 362% premium to its peers’ median range of 2.40 times.
Since, TTM earnings of Augmedix Inc (AUGX) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Augmedix Inc (AUGX) and enter the required number of quantities and click on buy to purchase the shares of Augmedix Inc (AUGX).
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California.
The CEO & director of Mr. Emmanuel Krakaris. is Augmedix Inc (AUGX), and CFO & Sr. VP is Mr. Emmanuel Krakaris.
There is no promoter pledging in Augmedix Inc (AUGX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Augmedix Inc (AUGX) | Ratios |
|---|---|
|
Return on equity(%)
|
-141.13
|
|
Operating margin(%)
|
-46.68
|
|
Net Margin(%)
|
-46.23
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Augmedix Inc (AUGX) was $0 Mln.
